6. Infections caused by common Gram-negative bacilli at Intensive Care Unit in Bach Mai Hospital in 2023
Main Article Content
Abstract
Infections caused by multidrug-resistant Gram-negative bacteria at the Intensive Care Unit (ICU) are a significant concern. The study was conducted to determine the role of Gram-negative bacteria pathogens isolated in 2023 and their antimicrobial sensitivity profiles. A. baumannii, K. pneumoniae, and P. aeruginosa were the leading pathogens, accounting for 49.7% of all isolated pathogens. These bacteria all showed low sensitivity to antibiotics, including the new one, ceftazidime/avibactam. This study provides a database for clinicians to select empirical antibiotic treatment choices, especially for infections caused by carbapenem-resistant Gram-negative bacteria when susceptibility testing results are not yet available.
Article Details
Keywords
Gram-negative bacilli, intensive care unit
References
2. Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: The EUROBACT International Cohort Study. Intensive Care Med. 2012;38:1930-1945. doi: 10.1007/s00134 -012-2695-9.
3. World Health Organization. Antimicrobial resistance. Fact sheet. Published 2018. www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. 2023.
4. Nguyễn Thị Thủy, Vương Xuân Toàn, Nguyễn Quốc Tuấn. Tình hình nhiễm khuẩn của bệnh nhân mới vào khoa Hồi sức tích cực, Bệnh viện Bạch Mai năm 2021 - 2022. Tạo chí Y học Việt Nam. 2023;523(2). doi.org/10.51298/vmj.v523i2.4562.
5. Barrasa-Villar JI, Aibar-Remón C, Prieto-Andrés P, et al. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. 2017;15(65):644-652. doi.org/10.1093/cid/cix4 11.
6. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18:318-327. doi.org/10.1016/S1473-3099(17)30753-3.
7. CLSI. Analysis and Presentation of Cumulative Antimocrobial Susceptibility Test Data. 5th ed. CLSI guideline M39. Clinical and Laboratory Standards Institute. 2022.
8. CLSI. Performance Standards for antimicrobial susceptibility testing. 34th Ed. CLSI suplement M100. Clinical and Laboratory Standards Institute. 2024.
9. MacVane SH. Antimicrobial resistance in the intensive care unit: a focus on Gram-negative bacterial infections. J Intensive Care Med. 2017;32:25-37.
10. Retamar P, Portillo MM, Lopez-Prieto et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56:472-478.
11. Giang TM, Thao HLP, Duc TH, et al. Patterns of antimicrobial resistance in intensive care unit patients: A study in Vietnam. BMC Infect Dis. 2017;17:429.
12. Phu VD, Wertheim HFL, Larsson M, et al. Burden of hospital acquired infections and antimicrobial use in Vietnamese adult intensive care units. Plos One. 2016;11:e0147544.
13. Saharman YR, Karuniawati A, Severin JA, et al. Infections and antimicrobial resistance in intensive care units in lower-middle income countries: a scoping review. Antimicrob Resist Infect Control. 2021;(22):10 doi.org/10.1186/s13756-020-00871-x.
14. Sader HS, Mendes RE, Streit JM, et al. Antimicrobial susceptibility of Gram-negative bacteria from intensive care unit and non-intensive care unit patients from United States hospitals (2018-2020). Diag Microbiol Infect Dis. 2022;102:115557.
15. Johansson M, Phuong DM, Walther SM, et al. Need for improved antimicrobial and infection control stewardship in Vietnamese intensive care units. Trop Med Int Health. 2011. doi.org/10.1111/j.1365-3156.2011.02753.x.
16. Yahav D, Giske CG, Graamatniece A, et al. New β-lactam- β-lactamase inhibitor combinations. Clin Microbiol Rev. 2021. doi.org/10.1128/CMR.00115-20.